查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1629186

白喉、百日咳和破伤风 (DPT) 疫苗市场，按类型、年龄层、最终用户、国家和地区 - 2024-2032 年行业分析、市场最终用户、市场份额和预测

Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market, By Type, By Age Group, By End User, By Country, and By Region - Industry Analysis, Market End User, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 303 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告要点

2023年白喉、百日咳和破伤风(DPT)疫苗市场最终用户价值为56.2032亿美元，2024年至2032年复合年增长率为8.30%。

白喉、百日咳和破伤风 (DPT) 疫苗市场-市场动态

婴儿和儿童中百白破相关疾病的盛行率不断上升，以及政府计划提高意识，预计将推动市场需求

政府和组织加强教育人们疫苗接种的重要性，这正在促进市场成长。世卫组织的扩大免疫规划 (EPI) 和全球疫苗免疫联盟 (疫苗联盟) 等计画强调需要针对与百白破 (DPT) 相关的疾病进行广泛的免疫接种。对白喉、百日咳和破伤风风险（尤其是儿童）风险的进一步了解推动了需求。此外，百白破疫苗纳入国家免疫规划也刺激了市场需求。许多政府以很少的成本或免费提供疫苗，使服务不足的人能够获得疫苗。

婴儿和幼儿特别容易感染百白破相关疾病。在非洲和亚洲部分地区等出生率较高的国家或地区，五岁以下儿童数量的不断增加推动了对百白破疫苗的需求。 DPT 通常与其他疫苗如B型肝炎、小儿麻痹症结合使用，以便于管理，提高市场渗透率。此外，疫苗储存和分发方面的进步增强了偏远地区的可及性。由于免疫力下降而导致百日咳定期爆发，凸显了加强剂量和高疫苗接种率的必要性。白喉和百日咳等疾病的根除和控制工作优先考虑百白破疫苗。消除孕产妇和新生儿破伤风 (MNT) 计画等措施支持持续接种疫苗。

白喉、百日咳和破伤风 (DPT) 疫苗市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 8.30% 左右的复合年增长率成长

根据类型细分，预计 DTaP 疫苗细分市场将在 2023 年显示最大市场份额，这主要归功于世卫组织的建议。

根据年龄组细分，由于世界卫生组织规范制定了强制性百白破疫苗，儿科细分市场在 2023 年成为领先的年龄组细分市场。

根据最终用户细分，医院细分市场是 2023 年领先的最终用户细分市场，这主要是由于人们对医院疫苗接种和专案的认识不断提高。

从地区来看，由于亚洲国家人口的成长，亚太地区是 2023 年的主要收入来源。

白喉、百日咳和破伤风 (DPT) 疫苗市场-細項分析：

全球白喉、百日咳和破伤风 (DPT) 疫苗市场根据类型、年龄层、最终用户和地区进行细分。

市场依类型分为三类：DTaP疫苗、TD疫苗和TDaP疫苗。 DTaP 疫苗领域在市场上占据主导地位。预防传染病流行的日益增长的需求正在推动该细分市场的成长。

市场依年龄层分为两类：成人和儿童。儿科领域在市场上占据主导地位。儿科团体对疫苗接种前计划的认识不断提高，主要补充了细分市场的成长。

根据最终用户，市场分为三类：医院、诊所和其他。预计医院部门在预测期内将以最快的速度成长。世界卫生组织和联合国儿童基金会以消除孕产妇破伤风、小儿麻痹为目标的疫苗接种计画数量不断增加，预计将促进市场需求。

白喉、百日咳和破伤风 (DPT) 疫苗市场 - 地理洞察

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太、中东和非洲等地区。在北美，由于严格的公共卫生规定，疫苗接种覆盖率很高。完善的医疗基础设施确保了疫苗的广泛普及。在亚太地区，由于印度、中国和东南亚等国家的高出生率和大量婴儿人口而迅速增长。全球疫苗和免疫联盟、世界卫生组织等全球组织对低收入地区免疫规划的支持。印度和中国都是主要市场，既是疫苗消费国，也是疫苗生产国。

白喉、百日咳和破伤风 (DPT) 疫苗市场-竞争格局：

白喉、百日咳和破伤风（DPT）疫苗市场的特点是各大製药公司之间竞争激烈、不断创新和策略合作伙伴关係。市场正在转向先进的组合疫苗，如五价和六价製剂，其中包括针对B型肝炎和 Hib 等疾病的额外抗原。这些创新减少了综合免疫计画所需的注射次数。强生公司、葛兰素史克、血清研究所、Bionet-Asia 和明治控股是百白破疫苗领域的一些知名参与者。

2023年，赛诺菲巴斯德在美国市场推出六合一免疫疫苗Hexacima。

2022 年，默克公司与 Thermos 合作增强疫苗储存和分配技术。

目录

第 1 章：白喉、百日咳和破伤风 (DPT) 疫苗市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 白喉、百日咳和破伤风 (DPT) 疫苗市场摘要（按类型）
    • 白喉、百日咳和破伤风 (DPT) 疫苗市场片段（按年龄层）
    • 白喉、百日咳和破伤风 (DPT) 疫苗市场片段（按最终用户）
    • 白喉、百日咳和破伤风 (DPT) 疫苗市场片段（按国家/地区）
    • 白喉、百日咳和破伤风 (DPT) 疫苗市场片段（按地区）
  • 竞争洞察

第 3 章：白喉、百日咳和破伤风 (DPT) 疫苗主要市场趋势

  • 白喉、百日咳和破伤风 (DPT) 疫苗市场驱动因素
    • 市场驱动因素的影响分析
  • 白喉、百日咳和破伤风 (DPT) 疫苗市场限制
    • 市场限制影响分析
  • 白喉、百日咳和破伤风 (DPT) 疫苗市场机会
  • 白喉、百日咳和破伤风 (DPT) 疫苗市场未来趋势

第 4 章：白喉、百日咳和破伤风 (DPT) 疫苗产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：白喉、百日咳和破伤风 (DPT) 疫苗市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：白喉、百日咳和破伤风 (DPT) 疫苗市场格局

  • 2023 年白喉、百日咳和破伤风 (DPT) 疫苗市占率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：白喉、百日咳和破伤风 (DPT) 疫苗市场 - 按类型

  • 概述
    • 按类型分類的细分市场占有率分析
    • 百白破疫苗
    • TD 疫苗
    • TDaP 疫苗

第 8 章：白喉、百日咳和破伤风 (DPT) 疫苗市场 - 按年龄组

  • 概述
    • 按年龄组别分類的细分市场占有率分析
    • 成年人
    • 儿科

第 9 章：白喉、百日咳和破伤风 (DPT) 疫苗市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 医院
    • 诊所
    • 其他的

第 10 章：白喉、百日咳和破伤风 (DPT) 疫苗市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美白喉、百日咳和破伤风 (DPT) 疫苗主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按类型）
    • 北美市场规模和预测（按年龄组）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲白喉、百日咳和破伤风 (DPT) 疫苗主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模与预测（按类型）
    • 欧洲市场规模和预测（按年龄层）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区白喉、百日咳和破伤风 (DPT) 疫苗主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（按类型）
    • 亚太地区市场规模与预测（依年龄层）
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲白喉、百日咳和破伤风 (DPT) 疫苗主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按类型）
    • 拉丁美洲市场规模与预测（按年龄层）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲白喉、百日咳和破伤风 (DPT) 疫苗主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按类型）
    • 中东和非洲市场规模及预测（按年龄层）
    • 中东和非洲市场规模及预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析 - 白喉、百日咳和破伤风 (DPT) 疫苗产业

  • 竞争仪表板
  • 公司简介
    • GlaxoSmithKline (GSK)
    • Sanofi Pasteur
    • Merck & Co.
    • Serum Institute of India
    • Biological E Limited
    • Pfizer Inc.
    • Johnson & Johnson
    • CSL Limited
    • China National Pharmaceutical Group Corporation
    • Bharat Biotech
    • Novartis AG
    • Panacea Biotec
    • Valneva SE
    • Bionet-Asia
    • Meiji Holdings Co., Ltd.
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV4492

REPORT HIGHLIGHT

Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market End User was valued at USD 5,620.32 Million in 2023, expanding at a CAGR of 8.30% from 2024 to 2032.

The Diphtheria, Pertussis, and Tetanus (DPT) vaccine is a combination vaccine that provides protection against serious bacterial infections. These vaccines reduce the risk of infection and serious complications, especially in young children.

Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market- Market Dynamics

Increasing prevalence of DPT-related diseases among infant & children and rising awareness spread by government programs is expected to propel market demand

Increased efforts by governments and organizations to educate populations about the importance of vaccination is promoting market growth. Programs like WHO's Expanded Program on Immunization (EPI) and GAVI, the Vaccine Alliance, emphasize the need for widespread immunization against DPT-related diseases. Improved understanding of the risks of diphtheria, pertussis, and tetanus, particularly in children, drives demand. Also, the inclusion of the DPT vaccine in national immunization schedules boosts market demand. Many governments provide vaccines at little or no cost, making them accessible to underserved populations.

Infants and young children are particularly susceptible to DPT-related diseases. In the countries or regions with high birth rates, such as Africa and parts of Asia, the growing number of children under five drives the need for DPT vaccines. DPT is often combined with other vaccines like hepatitis B, polio for ease of administration, improving market penetration. Additionally, advancements in vaccine storage and distribution enhance accessibility in remote areas. Periodic pertussis outbreaks due to waning immunity have underscored the need for booster doses and high vaccination rates. Eradication and control efforts for diseases like diphtheria and pertussis prioritize DPT vaccines. Initiatives like maternal and neonatal tetanus (MNT) elimination programs support consistent vaccine uptake.

Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.30% over the forecast period (2024-2032)

Based on Type segmentation, the DTaP vaccines segment was predicted to show maximum market share in the year 2023, mainly owing to WHO's recommendation.

Based on Age Group segmentation, the pediatrics segment was the leading Age Group segment in 2023, due to mandatory DTP vaccines made by WHO norms.

Based on End User segmentation, the hospitals segment was the leading End User segment in 2023, mainly due to rising awareness among people about vaccination & programs by hospitals.

On the basis of region, Asia Pacific was the leading revenue generator in 2023, due to the rise in the population across Asian countries.

Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market- Segmentation Analysis:

Global Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market is segmented on the basis of Type, Age Group, End User, and Region.

The market is divided into three categories based on the Type: DTaP vaccines, TD vaccines, and TDaP vaccines. The DTaP vaccines segment dominates the market. The growing need to prevent infectious disease prevalence is boosting segment growth.

The market is divided into two categories based on Age Group: adults and pediatrics. The pediatrics segment dominates the market. The increasing awareness among pediatrics groups about pre-vaccination programs is primarily supplementing segment growth.

The market is divided into three categories based on End User: hospitals, clinics, and others. The hospital segment is anticipated to grow at the fastest rate over the forecast period. The growing number of vaccination programs with WHO & UNICEF goals with maternal tetanus elimination, polios are expected to foster market demand.

Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. In North America, there is high vaccination coverage due to stringent public health mandates. Established healthcare infrastructure ensures widespread vaccine access. In Asia Pacific, rapidly growing due to high birth rates and large infant populations in countries like India, China, and Southeast Asia. Support from global organizations such as GAVI, WHO for immunization programs in low-income areas. India and China are major markets, both as vaccine consumers and producers.

Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market- Competitive Landscape:

The Diphtheria, Pertussis, and Tetanus (DPT) vaccine market is characterized by intense competition among major pharmaceutical companies, continuous innovations, and strategic partnerships. The market is moving towards advanced combination vaccines like pentavalent and hexavalent formulations, which include additional antigens for diseases like hepatitis B and Hib. These innovations reduce the number of injections required for comprehensive immunization programs. Johnson & Johnson, GSK, Serum Institute, Bionet-Asia, and Meiji Holdings are some of the prominent players in the DPT vaccine space.

In 2023, Sanofi Pasteur launched Hexacima a six in a one immunization Vaccine in the U.S. market.

In 2022, Merck & Co. collaborated with Thermos to enhance vaccine storage and distribution technologies.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL DIPHTHERIA, PERTUSSIS, AND TETANUS (DPT) VACCINE MARKET KEY PLAYERS

  • GlaxoSmithKline (GSK)
  • Sanofi Pasteur
  • Merck & Co.
  • Serum Institute of India
  • Biological E Limited
  • Pfizer Inc.
  • Johnson & Johnson
  • CSL Limited
  • China National Pharmaceutical Group Corporation
  • Bharat Biotech
  • Novartis AG
  • Panacea Biotec
  • Valneva SE
  • Bionet-Asia
  • Meiji Holdings Co., Ltd.
  • Others

GLOBAL DIPHTHERIA, PERTUSSIS, AND TETANUS (DPT) VACCINE MARKET, BY TYPE- MARKET ANALYSIS, 2019-2032

  • DTaP vaccines
  • TD vaccines
  • TDaP vaccines

GLOBAL DIPHTHERIA, PERTUSSIS, AND TETANUS (DPT) VACCINE MARKET, BY AGE GROUP- MARKET ANALYSIS, 2019-2032

  • Adults
  • Pediatrics

GLOBAL DIPHTHERIA, PERTUSSIS, AND TETANUS (DPT) VACCINE MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

  • Hospitals
  • Clinics
  • Others

GLOBAL DIPHTHERIA, PERTUSSIS, AND TETANUS (DPT) VACCINE MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market Snippet by Type
    • 2.1.2. Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market Snippet by Age Group
    • 2.1.3. Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market Snippet by End User
    • 2.1.4. Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market Snippet by Country
    • 2.1.5. Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market Snippet by Region
  • 2.2. Competitive Insights

3. Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Key Market Trends

  • 3.1. Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market Opportunities
  • 3.4. Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market Future Trends

4. Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market Landscape

  • 6.1. Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
    • 7.1.2. DTaP vaccines
    • 7.1.3. TD vaccines
    • 7.1.4. TDaP vaccines

8. Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market - By Age Group

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Age Group, 2024 & 2032 (%)
    • 8.1.2. Adults
    • 8.1.3. Paediatrics

9. Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Clinics
    • 9.1.4. Others

10. Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. GlaxoSmithKline (GSK)
    • 11.2.2. Sanofi Pasteur
    • 11.2.3. Merck & Co.
    • 11.2.4. Serum Institute of India
    • 11.2.5. Biological E Limited
    • 11.2.6. Pfizer Inc.
    • 11.2.7. Johnson & Johnson
    • 11.2.8. CSL Limited
    • 11.2.9. China National Pharmaceutical Group Corporation
    • 11.2.10. Bharat Biotech
    • 11.2.11. Novartis AG
    • 11.2.12. Panacea Biotec
    • 11.2.13. Valneva SE
    • 11.2.14. Bionet-Asia
    • 11.2.15. Meiji Holdings Co., Ltd.
    • 11.2.16. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us